FOOD LAW AND NEW TECHNOLOGIES IN POLAND

When we are currently witnessing a constantly changing environment, the phrase ‘food law’ or ‘agriculture law’ is not sufficient to describe the situation by legal terms. What can be observed in the market is that the food sector and new technologies sector have stepped up cooperation and co-work. Such new products as vegan meat, soya, coconut, almond milk, mechanic bees are a result of food-tech cooperation. The food tech cooperation comprises a considerable part of the market in Poland, effecting in the creation of a number of start-ups, such as for example:

• Qurczak which produces a unique plant- based alternative to poultry meat, made of fibers that resemble chicken breast;
• Frens which produces a hypoallergenic and easily digestible food for dogs containing insect protein;
• KuMin.Sys which is an IT tool for catering industry to help better plan production volumes, optimization of costs and reduction of food waste.

The above start-ups function in the Foodtech accelerator https://foodtech.ac. This is one of the many examples of enhanced cooperation between food and technology (especially IT) sectors. Behind these innovative ideas there is always specific legal regulation which controls and moderates the business reality.

POLISH AND EUROPEAN FOODTECH LEGAL FRAMEWORK

In Poland there are the following main legal acts which contain the relevant provisions in the discussed sector:

More

Considering global food and agricultural problems KIEŁTYKA GŁADKOWSKI KG LEGAL PROFESSIONAL PARTNERSHIP. ATTORNEY LAW FIRM will take part in the FoodTech Expo, International Food Technology Fair (2^nd edition) on 23-25 November 2021 in Warsaw.

The Food Technology Fair is a presentation of a comprehensive offer of producers and distributors of machines for food processing and production, technologies increasing food safety, and presentation of additives and components for food and novel food.

The participants of the Foodtech Fair will include, among others, the representatives of the main players in the foodtech market, like the companies of specialist machines and technological liners for the food industry sector; machines and supporting devices, accessories; food production components and additives; services, research and science.

FoodTech and AgTech law sectors remain within the specialization of KIELTYKA GLADKOWSKI law firm, with emphasis on Agricultural robotics, crop science, plant based eco-friendly meat and regulatory aspects of the latter, machine learning and technology in agtech and foodtech.

Home

More

On September 1, 2021, as members of American Bankruptcy Institute KIELTYKA GLADKOWSKI will take part in the webinar Cryptocurrency: Valuation issues and market volatility, sponsored by the Financial Advisors and Investment Banking Committee.

The American Bankruptcy Institute is the US largest and most diverse community of bankruptcy professionals. ABI provides essential resources for insolvency professionals including:

• Opinions
• Consumer commission
• Blog exchange
• ABI Law Review
• Daily news headlines on insolvency developments around the globe
• ABI Journal

During the webinar three cryptocurrency industry experts – a lawyer, a technical consultant and an investment banker will cover the complexity of valuing cryptocurrency and provide their expert views on the crypto-market volatility, both currently and going forward. The presenters will also offer their insights into the adoption of cryptocurrency in the U.S. and globally, and will address regulatory changes in banking as they relate to cryptocurrencies.

More

This text is an instruction on how to go through the electronic procedure on the KRS (National Court Register) Portal to set up a simple joint-stock company in the e-forms National Court Register application. We are going to show you a shortened and simplified procedure in few steps on which the applicant should (must) follow.

1. Log in on the Court Register Portal and open the  National Court Register e-forms application program home page.
2. In the application homepage, in the ‘Submit an application or an official letter’ section, on the ‘Applications’ tab, select the application category ‘Application for registration’ and click the [Go to the petition].
3. On the ‘Submit application’s’ screen, select the legal form of the entity ‘Companies’.
4. Select ‘Simple Joint- Stock Company’ from the list of available legal forms. On the screen will be displayed the first tab of the application entry form for entity registration in the register of entrepreneurs for a Simple Joint- Stock Company.
5. Complete the ‘Application name’ tab. Leave the name suggested by the system, modify it or input your own name of the application.
6. Complete the ‘Applicant/ Representative’ tab.

More

On 29 July 2021 KIEŁTYKA GŁADKOWSKI KG LEGAL took part in the webinar ‘Cell and gene data innovation and multi-stakeholder data transfer’ (Plan, capture and set the infrastructure for data sharing across the value chain, to optimize commercial strategy), organized by Reuters Events in participation and partnership with Salesforce. The scope of the webinar is within life science and digital health specialization that constitutes one of the core specializations of our law firm.

Some of the panelists included:

Augusto Penjasoff – Business Partner, Global Cell Therapy IT Head in BMS (Bristol Myers Squibb),

Curt Fitzgerald – Director- Service Delivery- C&GT in Novartis,

Gary Gabriel – Global Advisor for Healthcare and Life Sciences in Tableau,

Neary Detrick – Senior Director, Data Management & Analytics in Bluebird Bio,

and Beth Hayes as a moderator- healthcare and lifesciences business consulting – Pharma Lead, Industry Transformation (Salesforce).

The mission of Salesforce company (a partner and a participant of the webinar) is to empower companies to connect with the customers, providers of services and patients in the new and reimagined way. Salesforce serves leading organizations across the industry, including pioneers in CGT (cell and gene therapy).

Important question posed during the webinar concerned personalized medicine.

The response is that the latter is the future of the medicine (so-called a Medicine 2.0). A deliberation about personalized medicine is not a discussion about future in about 10 or 15 years. It drives a magnificent impact across the industry. There was also discussed the question of the difference between the traditional medicine and personalized medicine.

More